Neuropathic pain: our best treatments still fall short
Despite a large body of new evidence, our best treatments for neuropathic pain continue to provide only modest benefits.
Showing results for:
Strangling the poor in red tape: the role of administrative harms
Many vulnerable people are excluded from the support they need by administrative red tape that leaves them overwhelmed and disempowered, writes Dr Louise Stone.
Fast-tracking monoclonal antibody therapy for patients with severe asthma
Monoclonal antibody therapies for severe asthma can reduce risky corticosteroid loads, but are still underutilised, writes clinical associate professor Debbie Rigby.
Extreme heat poses a threat to mental health
Rising temperatures could increase the burden of mental and behavioural disorders by nearly 50% by 2050, challenging Australia’s health care system.
Screening made easy for sleep apnoea in general practice
A new screening tool, The General Practice Sleep Scale, holds promise as a practical, real-world solution to obstructive sleep apnoea underdiagnosis in general practice.
Running on fumes for years: junior doctors say system is unsafe, not just underfunded
Junior doctors in New South Wales have long decried what they describe as unsafe working conditions and unequal pay. In February, junior doctors went on strike after a leaked email referred to the group as “marshmallow...
More people are trying medicinal cannabis for chronic pain. But does it work?
More Australians than ever are being prescribed medicinal cannabis.
Improving treatment for those living with anxiety
The Living with Anxiety study aims to identify genes that influence a person’s risk of developing anxiety disorders and genes that impact how well treatments for anxiety work.
The necessity of a permanent ceasefire in Gaza
A temporary ceasefire is being observed in Gaza after 15 months of conflict between Hamas and Israel. Tens of thousands of Palestinians have been killed and many more injured. The targeting and destruction of health care...
